Published in JAMA on July 05, 2000
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol (2008) 3.63
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Impact of UK Medical Eligibility Criteria implementation on prescribing of combined hormonal contraceptives. J Fam Plann Reprod Health Care (2013) 2.06
Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview. PLoS Med (2011) 2.06
Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci (2001) 1.39
Meta-analysis: neither quick nor easy. BMC Med Res Methodol (2002) 1.38
Sex differences in stroke. J Cereb Blood Flow Metab (2012) 1.21
Stroke risk in women: the role of menopause and hormone therapy. Lancet Neurol (2012) 1.10
Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event. BMC Med Res Methodol (2012) 1.01
Transdermal estradiol for postpartum depression: a promising treatment option. Clin Obstet Gynecol (2009) 1.01
Sex-specific responses to stroke. Future Neurol (2010) 0.96
Contraindications to combined oral contraceptives among over-the-counter compared with prescription users. Obstet Gynecol (2011) 0.95
Female reproductive factors and primary open-angle glaucoma in the Nurses' Health Study. Eye (Lond) (2011) 0.94
Migraine and stroke: the role of oral contraceptives. Neurol Sci (2008) 0.93
The third generation pill controversy ("continued"). BMJ (2001) 0.92
[Prevention of stroke]. Wien Med Wochenschr (2003) 0.92
Stroke in women: risk and prevention throughout the lifespan. Neurol Clin (2008) 0.91
Hormonal contraceptive options for women with headache: a review of the evidence. Rev Obstet Gynecol (2010) 0.86
Estrogen and neuroprotection: from clinical observations to molecular mechanisms. Dialogues Clin Neurosci (2002) 0.86
A cross-sectional study of different patterns of oral contraceptive use among premenopausal women and circulating IGF-1: implications for disease risk. BMC Womens Health (2011) 0.84
Hormonal contraception in women with migraine: is progestogen-only contraception a better choice? J Headache Pain (2013) 0.83
Comparison of pooled risk estimates for adverse effects from different observational study designs: methodological overview. PLoS One (2013) 0.81
Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study. BMJ (2014) 0.81
Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke. Horm Behav (2012) 0.81
Choosing a combined oral contraceptive pill. Aust Prescr (2015) 0.80
Sex-related differences in migraine. Neurol Sci (2014) 0.79
Estrogens and Stroke: Use of Oral Contraceptives and Postmenopausal Use of Estrogen: Current Recommendations. Curr Treat Options Neurol (2004) 0.79
What about clonidine for diarrhoea? A systematic review and meta-analysis of its effect in humans. Therap Adv Gastroenterol (2016) 0.77
Sex differences in predictors of ischemic stroke: current perspectives. Vasc Health Risk Manag (2015) 0.77
Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives. J Neurol Neurosurg Psychiatry (2006) 0.76
Prevention opportunities for oral contraceptive-associated ischemic stroke. Stroke (2014) 0.76
Risk factors of transient ischemic attack: An overview. J Midlife Health (2016) 0.76
Positive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days. J Headache Pain (2015) 0.76
Clinical pharmacology and vascular risk. Open Neurol J (2010) 0.75
Regarding "meta-analysis and causal inference: a case study of benzene and non-Hodgkin lymphoma": an incomplete analysis. Ann Epidemiol (2010) 0.75
Migraine and ischaemic stroke. BMJ (2005) 0.75
The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke (2001) 8.73
Spinal manipulative therapy is an independent risk factor for vertebral artery dissection. Neurology (2003) 4.32
Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: a multicenter study. Neurology (2011) 2.62
Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke (2001) 1.97
Secondary preventive medication persistence and adherence 1 year after stroke. Neurology (2011) 1.62
Deaths from stroke in US children, 1979 to 1998. Neurology (2002) 1.58
Evaluation of carotid stenosis using CT angiography in the initial evaluation of stroke and TIA. Neurology (2004) 1.57
Structure of the proteasome activator REGalpha (PA28alpha). Nature (1997) 1.56
Inpatient statin use predicts improved ischemic stroke discharge disposition. Neurology (2012) 1.53
A randomized trial of hypothesis-driven vs screening neurologic examination. Neurology (2011) 1.53
Do the Brain Attack Coalition's criteria for stroke centers improve care for ischemic stroke? Neurology (2005) 1.52
Is mechanical clot removal or disruption a cost-effective treatment for acute stroke? AJNR Am J Neuroradiol (2011) 1.51
Transient ischemic attacks characterized by RNA profiles in blood. Neurology (2011) 1.49
Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators. J Biol Chem (1997) 1.47
Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12. EMBO J (2000) 1.34
Arterial dissection and stroke in children. Neurology (2001) 1.34
Incidence and mortality of generalized convulsive status epilepticus in California. Neurology (2002) 1.30
Education and the cognitive decline associated with MRI-defined brain infarct. Neurology (2006) 1.20
Characteristics of academic medical centers and ischemic stroke outcomes. Stroke (2001) 1.11
Unruptured intracranial aneurysms: the unreliability of clinical judgment, the necessity for evidence, and reasons to participate in a randomized trial. J Neuroradiol (2006) 1.03
The 5-year direct medical cost of neonatal and childhood stroke in a population-based cohort. Neurology (2010) 1.00
Trial on endovascular treatment of unruptured aneurysms (TEAM): study monitoring and rationale for trial interruption or continuation. J Neuroradiol (2007) 0.96
Stroke risk factors and loss of high cognitive function. Neurology (2004) 0.92
Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. J Am Coll Cardiol (2001) 0.92
Large scale production and purification of paraquat and desipramine monoclonal antibodies and their Fab fragments. Int J Immunopharmacol (1988) 0.89
Stent-assisted coiling versus coiling alone in unruptured intracranial aneurysms in the matrix and platinum science trial: safety, efficacy, and mid-term outcomes. AJNR Am J Neuroradiol (2013) 0.87
Repeated hemoperfusion and continuous arteriovenous hemofiltration in a paraquat poisoned patient. J Toxicol Clin Toxicol (1987) 0.83
Obstacles to primary stroke prevention in children with sickle cell disease. Neurology (2006) 0.82
Prognostication matters. Muscle Nerve (2000) 0.82
Unruptured intracranial aneurysms: their illusive natural history and why subgroup statistics cannot provide normative criteria for clinical decisions or selection criteria for a randomized trial. J Neuroradiol (2008) 0.82
The thickness of the temporal squama and its implication for transcranial sonography. J Neuroimaging (2004) 0.81
Evaluation of equilibrium constants for antigen-antibody interactions by solid-phase immunoassay: the binding of paraquat to its elicited mouse monoclonal antibody. Mol Immunol (1987) 0.81
Intraprocedural rupture of aneurysms: not necessarily a small problem. AJNR Am J Neuroradiol (2009) 0.75
Distinguishing intracerebral hemorrhages caused by arteriovenous malformations. Cerebrovasc Dis (2003) 0.75
Surface figure changes due to thermal cycling hysteresis. Appl Opt (1987) 0.75
Dimensional instability of Invars. Appl Opt (1984) 0.75
The use of the Rines model in differentiating professional and technical nursing practice. Nurs Health Care (1982) 0.75
Serum factors affecting the specificity of anticardiolipin antibodies. Immunol Cell Biol (1991) 0.75
Endogenous opioids modulate fetal rabbit lung maturation. J Appl Physiol (1985) (1987) 0.75
Expansion hysteresis upon thermal cycling of Zerodur. Appl Opt (1984) 0.75
Confocal optical feedback processing system: an improved optical design. Appl Opt (1983) 0.75
A modified preceptorship experience. Nurse Educ (1995) 0.75
Counterpoint-target aneurysm recurrence: measuring what matters. AJNR Am J Neuroradiol (2014) 0.75
Some problems caused by birefringence in dielectric mirrors. Appl Opt (1986) 0.75